Fertility Drugs Market Global Report 2020-30 from the author provides the strategists, marketers and senior management with the critical information they need to assess the global fertility drugs market.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the fertility drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Fertility Drugs market global report from the author answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider fertility drugs market, and compares it with other markets.
Scope
Markets Covered: 1) By Gender: Male; Female; 2) By Route of Administration: Oral; Intravenous; Subcutaneous; Intramuscular; 3) By Type Of Drug: Prescription Fertility Drugs; Over-The-Counter Fertility drugs; 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Merck & Co.; Ferring Pharmaceuticals; Bayer; Berlex Laboratories Inc.; Janssen Pharmaceutical Inc.
Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the fertility drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Fertility Drugs market global report from the author answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider fertility drugs market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
- The fertility drugs market section of the report gives context. It compares the fertility drugs market with other segments of the fertility drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, fertility drugs indicators comparison.
Scope
Markets Covered: 1) By Gender: Male; Female; 2) By Route of Administration: Oral; Intravenous; Subcutaneous; Intramuscular; 3) By Type Of Drug: Prescription Fertility Drugs; Over-The-Counter Fertility drugs; 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Merck & Co.; Ferring Pharmaceuticals; Bayer; Berlex Laboratories Inc.; Janssen Pharmaceutical Inc.
Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1. Executive Summary2. Fertility Drugs Market Characteristics26. Key Mergers And Acquisitions In The Fertility Drugs Market27. Fertility Drugs Market Trends And Strategies28. Fertility Drugs Market Future Outlook and Potential Analysis
3. Fertility Drugs Market Size And Growth
4. Fertility Drugs Market Segmentation
5. Fertility Drugs Market Regional And Country Analysis
6. Asia-Pacific Fertility Drugs Market
7. China Fertility Drugs Market
8. India Fertility Drugs Market
9. Japan Fertility Drugs Market
10. Australia Fertility Drugs Market
11. Indonesia Fertility Drugs Market
12. South Korea Fertility Drugs Market
13. Western Europe Fertility Drugs Market
14. UK Fertility Drugs Market
15. Germany Fertility Drugs Market
16. France Fertility Drugs Market
17. Eastern Europe Fertility Drugs Market
18. Russia Fertility Drugs Market
19. North America Fertility Drugs Market
20. USA Fertility Drugs Market
21. South America Fertility Drugs Market
22. Brazil Fertility Drugs Market
23. Middle East Fertility Drugs Market
24. Africa Fertility Drugs Market
25. Fertility Drugs Market Competitive Landscape And Company Profiles
29. Appendix
Executive Summary
The fertility drugs market consists of sales of fertility drugs and related services used to aid the production of sperms and eggs in order to promote fertility among men and women. Fertility drugs are the primary treatment for infertility and increase the chances of producing an offspring by stimulating and regulating ovulation in women and increasing the sperm count in men.The global fertility drugs market was worth $4.26 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 5.80% and reach $5.33 billion by 2023.
The fertility drugs market covered in this market is segmented by gender into male; female. It is also segmented by route of administration into oral; intravenous; subcutaneous; intramuscular, by type of drug into prescription fertility drugs; over-the-counter fertility drugs and by distribution channel into hospital pharmacies; retail pharmacies; online pharmacies.
The growth of the fertility drugs market is driven by the increasing rates of infertility across the globe. Infertility is the inability to conceive after trying for 12 consecutive months. Fertility drugs are considered to be the primary treatment to treat infertility in men and women. The rising rates of infertility is attributed to physiological problems, hormone problems, and lifestyle or environmental factors. To treat infertility problems in women, fertility drugs are used to regulate their ovulation cycles thus affecting the sale of fertility drugs. According to the USA National Survey of Family Growth (NSFG) in 2018, about 15.5% of all women who intend to become pregnant were infertile and 6.7% of married women aged 15 to 44 years were infertile. Further, in 2019, in India, 10% to 15% of couples in reproductive age group are suffering from infertility. Hence, the rising cases of infertility across the globe is increasing the demand for fertility drugs, resulting in the growth of fertility drugs market.
The side effects caused due to fertility drugs restricted the growth of the fertility drugs market. Fertility drugs can result in permanent as well as temporary side effects. Temporary side effects includes bloating, headache, breast tenderness, upset stomach, hot flashes, and mood swings whereas the permanent side effects includes multiple pregnancies, ovarian hyperstimulation syndrome (OHSS). OHSS is a condition where the ovaries enlarge with fluids and may become life threating if left untreated. For instance, the intake of Clomid (clomiphene citrate), a fertility drug for women, can result in OHSS along with abnormal vaginal/uterine bleeding, breast tenderness or discomfort, headache, nausea, vomiting, diarrhoea, flushing, blurred vision or other visual disturbances. The fear of potential side effects of the fertility drugs restrict the growth of the fertility drugs market.
In 2019, Ferring Pharmaceuticals, a USA based biopharmaceutical company, acquired USA commercialization rights of Ganirelix Acetate Injection from Sun Pharmaceutical Industries Ltd for an amount undisclosed. Through the acquisition, Ferring Pharmaceutical aims to broaden its medicine portfolio targeted towards reproduction. Ganirelix Acetate Injection was approved by FDA in 2018 and is used to regulate premature luteinizing hormone (LH) levels in women undergoing fertility treatment. The Sun Pharmaceutical Industries Ltd is an India based manufacturer and seller of pharmaceutical formulations and active pharmaceutical ingredients.
Major players in the market are Merck & Co., Ferring Pharmaceuticals, Bayer, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer, Novartis AG, Procter & Gamble Pharmaceutical, Zydus Pharma and LIVZON.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Merck & Co.
- Ferring Pharmaceuticals
- Bayer
- Berlex Laboratories Inc.
- Janssen Pharmaceutical Inc.
- Pfizer
- Novartis AG
- Procter & Gamble Pharmaceutical
- Zydus Pharma
- LIVZON
- Abbott
- MSD
- Sanofi S.A.
- Eli Lilly and Co.
- Serono, Inc.
- Novogyne Pharmaceuticals
- Takeda Pharmaceutical co. ltd.
Methodology
LOADING...
